focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission of Shares, Voting Rights and Options

29 Nov 2018 10:20

RNS Number : 9016I
Location Sciences Group PLC
29 November 2018
 

29 November 2018

Location Sciences Group PLC

("Location Sciences" or the "Company")

Admission of Placing Shares, Total Voting Rights and Grant of Options

Location Sciences Group PLC (AIM: LSAI), the leading mobile location data and intelligence expert, announces that, pursuant to the completion of the Placing announced on 26 November 2018, 122,822,221 new ordinary shares of 1 pence each in the Company ("Ordinary Shares") were this morning admitted to trading on AIM. The Company's issued share capital now comprises 332,655,659 Ordinary Shares. This figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

The Company also announces that, pursuant to the approval by shareholders of Resolution 2 at the Company's general meeting held on 21 November 2018, approving the adoption of a new Enterprise Management Incentive (EMI) share option scheme for directors and key employees of the Company, the Board has this morning granted, subject to the surrendering of existing options, options to certain Directors as follows:

Mark Slade, CEO, has been granted 11,111,111 options under the EMI scheme and 4,444,444 unapproved options;

David Rae, CFO, has been granted 7,333,333 options under the EMI scheme; and

Kelvin Harrison, Non-Executive Chairman, has been granted 577,778 unapproved options.

 

All options were granted at an exercise price of 2.25 p, being the Placing Price. The options vest in tranches of one-third each when the closing mid market share price of the Company has exceeded 4.8 pence, 7.3 pence and 9.7 pence per Ordinary Share respectively, in each case calculated using a three month moving average of the share price of the Company. If the Company is acquired, the options will vest in all respects and become exercisable in full. Shares issued upon exercise, must be held for a minimum period of 12 months, again other than in the event of the acquisition of the Company. Unapproved options are granted on terms which are in all material respects identical to those granted under the EMI Scheme. All options lapse 10 years from the date of grant.

Save as defined herein, capitalised terms used in this announcement have the same meaning as in the Company's announcements of 26 November 2018.

For further information please contact:

Location Sciences Group PLC

Via Newgate Communications

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Stockdale Securities Limited

Tel: +44 (0)20 7601 6100

Tom Griffiths

 

Ed Thomas

 

 

 

Newgate Communications

Tel: +44 (0)20 3757 6880

Bob Huxford

 

Fiona Norman

 

 

About Location Sciences Group PLC:

 

Location Sciences helps companies connect the online world with the offline world using mobile location technology data. We combine cutting-edge mobile location data collection with proprietary machine learning analytics to create new value and insights from location information.

 

Location Sciences is media-agnostic and works with a variety of media, advertising and technology partners - plus the world's biggest brands. Our technology is well positioned to fulfil the need for greater accuracy and accountability in a growing market that is increasingly looking for superior data and verification.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFEWFSUFASEFF
Date   Source Headline
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
6th May 20217:00 amRNSResult of Broker Option
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
4th May 202111:05 amRNSSecond Price Monitoring Extn
4th May 202111:00 amRNSPrice Monitoring Extension
4th May 20219:05 amRNSSecond Price Monitoring Extn
4th May 20219:00 amRNSPrice Monitoring Extension
4th May 20217:00 amRNSProposed Fundraise of up to £3.85m - Notice of GM
23rd Apr 20212:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20212:00 pmRNSPrice Monitoring Extension
18th Mar 20217:00 amRNSFinal Results for the year ended 31 December 2020
15th Mar 20214:41 pmRNSSecond Price Monitoring Extn
15th Mar 20214:35 pmRNSPrice Monitoring Extension
23rd Feb 202111:00 amRNSPrice Monitoring Extension
19th Feb 20213:36 pmRNSTR-1 Notification of major holdings
11th Feb 202111:06 amRNSSecond Price Monitoring Extn
11th Feb 202111:00 amRNSPrice Monitoring Extension
11th Feb 20219:05 amRNSSecond Price Monitoring Extn
11th Feb 20219:00 amRNSPrice Monitoring Extension
11th Feb 20217:00 amRNSTrading Update and Directorate Changes
3rd Feb 20214:41 pmRNSSecond Price Monitoring Extn
3rd Feb 20214:36 pmRNSPrice Monitoring Extension
28th Jan 20214:41 pmRNSSecond Price Monitoring Extn
28th Jan 20214:36 pmRNSPrice Monitoring Extension
21st Jan 20214:41 pmRNSSecond Price Monitoring Extn
21st Jan 20214:36 pmRNSPrice Monitoring Extension
20th Jan 20214:40 pmRNSSecond Price Monitoring Extn
20th Jan 20214:35 pmRNSPrice Monitoring Extension
18th Dec 20207:00 amRNSHolding(s) in Company
17th Dec 20204:41 pmRNSSecond Price Monitoring Extn
17th Dec 20204:35 pmRNSPrice Monitoring Extension
16th Dec 20204:41 pmRNSSecond Price Monitoring Extn
16th Dec 20204:36 pmRNSPrice Monitoring Extension
14th Dec 20207:00 amRNSPotential Defamation Action Against the Company
30th Nov 20207:00 amRNSNew Contract Win and Trading Update
5th Nov 20203:44 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSIssue of shares to directors in lieu of fees & TVR
1st Oct 20207:00 amRNSAppointment of Nominated Adviser
17th Sep 202012:43 pmRNSHalf-year Report - Replacement
15th Sep 20207:00 amRNSHalf-year Report
1st Sep 20209:05 amRNSSecond Price Monitoring Extn
1st Sep 20209:00 amRNSPrice Monitoring Extension
1st Sep 20207:00 amRNSContract
27th Jul 20207:00 amRNSTrading Update
3rd Jul 202011:05 amRNSSecond Price Monitoring Extn
3rd Jul 202011:00 amRNSPrice Monitoring Extension
1st Jul 202010:02 amRNSIssue of Equity and Total Voting Rights
16th Jun 202010:36 amRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.